KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.
暂无分享,去创建一个
[1] F. Locatelli,et al. Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency. , 2001, Kidney international.
[2] A. Nissenson,et al. Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] S. Fishbane,et al. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. , 2005, Kidney international.
[4] B. Kanna,et al. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) study. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] A R Nissenson,et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. , 1998, The New England journal of medicine.
[6] J. Lazarus,et al. Impact of the Change in CMS Billing Rules for Erythropoietin on Hemoglobin Outcomes in Dialysis Patients , 2006, Blood Purification.
[7] H. Krum,et al. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis , 2007, The Lancet.
[8] H. Burger,et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. , 2006, The New England journal of medicine.
[9] A. Levin,et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. , 2000, Kidney international.
[10] A. Levin,et al. Effect of early correction of anemia on the progression of CKD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[11] S. Fishbane,et al. Hemoglobin variability in epoetin-treated hemodialysis patients. , 2003, Kidney international.
[12] M. Rudnick,et al. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] D Richardson,et al. Optimizing erythropoietin therapy in hemodialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] G. Y. Wong,et al. Precision of health-related quality-of-life data compared with other clinical measures. , 2007, Mayo Clinic proceedings.
[15] K. Siamopoulos,et al. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. , 2004, Kidney international.
[16] R. Foley,et al. Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] R. Foley,et al. Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. , 2005, Journal of the American Society of Nephrology : JASN.
[18] J. Singer,et al. Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] I. Macdougall,et al. Is early treatment of anaemia with epoetin-alpha beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[20] David Voss,et al. Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial. , 2004, Journal of the American Society of Nephrology : JASN.
[21] Eduardo Lacson,et al. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. , 2003, Kidney international.
[22] Alexander Tsertsvadze,et al. Systematic reviews: when is an update an update? , 2006, The Lancet.
[23] G. Guyatt,et al. Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group. , 1999, JAMA.
[24] G. Eknoyan,et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2006, Kidney international.
[25] C. Bartlett,et al. Structured conversion from thrice weekly to weekly erythropoietic regimens using a computerized decision-support system: a randomized clinical study. , 2005, Journal of the American Society of Nephrology : JASN.
[26] Y. Kawaguchi,et al. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. , 1997, Nephron.
[27] G. Beck,et al. Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias". , 2005, Journal of the American Society of Nephrology : JASN.
[28] J. Lazarus,et al. Effect of variability in anemia management on hemoglobin outcomes in ESRD. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] A. Christensson,et al. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] O. Djurdjev,et al. Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[31] V. Prasad. Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease , 2007 .